SOURCE: Skreem Entertainment Corporation

March 25, 2008 09:00 ET

Skreem Entertainment Signs LOI to Acquire Men's Health Medical Company

Current Revenues Exceed $24 Million, EBITDA $8 Million +

ORLANDO, FL--(Marketwire - March 25, 2008) - Skreem Entertainment Corporation (OTCBB: SKNT) announced today that it has signed a Letter of Intent to acquire EdMed, LLC. EdMed, LLC has executed a contract to purchase controlling interest in 22 men's health clinics which specialize in the treatment of Erectile Dysfunction (E.D.) and Premature Ejaculation (P.E.). The Company currently has revenues exceeding $24 Million and EBITDA of more than $8 Million with plans to expand to 120 clinics within three years.

Christopher Smith, President and C.E.O. of EdMed, LLC, said, "With an estimated 45 to 50 million males suffering from some form of erectile dysfunction, this has the potential to become one of the largest industries as measured in terms of patient expenditures as a percentage of their overall medical treatment. Medicare and an increasing number of private health-care providers are incorporating the treatment of E.D. and P.E. as part of their overall health coverage programs. We have developed a very conservative growth plan to expand from our base of 22 clinics to 120 clinics over the next three years. Men's personal health issues is a multi-billion dollar industry that is only now getting the attention and focus it deserves."

This press release may contain certain information about SKNT's business prospects and financial projections. These are only prospects and projections based upon good faith current expectations by the management of SKNT. This information is based on assumptions as to future events that are inherently uncertain and subjective. SKNT makes no representation or warranty as to the attainability of such assumptions or as to whether future results will occur as projected. You are expected to conduct your own investigation with regard to SKNT and its prospects. The company assumes no obligation to update the information in this press release.

Contact Information

  • For more information contact:

    Christopher Smith
    (Email Contact)

    Charles Camorata

    (407) 207-0400
    Fax (407) 207-0434